Cases & Deals

Idenix enforces patent against Gilead in Germany over sofosbuvir

Client(s) Idenix Pharmaceuticals LLC

Jones Day represented Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in Landgericht Düsseldorf in Germany over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.

Idenix v. Gilead Sciences et al, Landgericht Düsseldorf, Az: 4c O 5/14